WASHINGTON, D.C. — (AP) Abbott Laboratories said Friday it will withdraw its diet pill Meridia in the U.S. and Canada, after coming under pressure from health regulators who say the drug increases the risk of heart attack and stroke in patients... Read More
WASHINGTON, D.C. - (AP) For the second time in five years, public health advocates are calling on the Food and Drug Administration to ban a fat-blocking drug sold over-the counter and via prescription, pointing to new reports of kidney stones and pancreatic... Read More
CINCINNATI - (Mealey's) Citing the Supreme Court's rejection of implied preemption of pharmaceutical product liability in Wyeth v. Diana Levine (No. 06-1249, U.S. Sup.; 2009 U.S. LEXIS 1774), the Sixth Circuit U.S. Court of Appeals on Aug. 18... Read More
ABBOTT PARK, Ill. - (Mealey's) After an unfavorable assessment by a Food and Drug Administration expert committee regarding cardiovascular risk, Abbott Laboratories on Oct. 8 agreed with an FDA request to withdraw the weight-loss drug Meridia (sibutramine... Read More
PHILADELPHIA - (Mealey's) A claim for negligent design is not subsumed in Pennsylvania's prohibition on strict liability claims against pharmaceutical manufacturers, the state Superior Court ruled Aug. 2 in a case asserting that Wyeth's diet... Read More
FRANKFORT, Ky. -- A $42 million summary judgment in favor of 431 fen-phen plaintiffs against a group attorneys, two of whom are serving lengthy prison sentences stemming from allegations that they pocketed twice what their fee agreements called for, has... Read More